BIM
NAGE

BlackRock Investment Management’s Niagen Bioscience NAGE Stock Holding History

BlackRock Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$367K Hold
110,729
– – ﹤0.01% 3126
2016
Q3 		$330K Sell
110,729
-276
-0.2% -$1.01K ﹤0.01% 3164
2016
Q2 		$460K Buy
+111,005
New +$525K ﹤0.01% 3109

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Investment Management's NAGE Position: Q4 2016 in Review

BlackRock Investment Management held its Niagen Bioscience (NAGE) position steady in Q4 2016 at 110,729 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

BlackRock Investment Management first reported a position in NAGE in Q2 2016 and has held it in 3 quarters since. The position peaked at $460K in Q2 2016. 52 funds tracked by Wall St. Rank hold NAGE as of Q4 2016.

  • BlackRock Investment Management held 110,729 shares of Niagen Bioscience worth $367K as of Q4 2016.
  • BlackRock Investment Management left its Niagen Bioscience share count unchanged in Q4 2016.
  • Niagen Bioscience made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3126 holding.
  • BlackRock Investment Management first reported a position in Niagen Bioscience in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Investment Management's Niagen Bioscience position peaked at $460K in Q2 2016.
  • 52 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.